Warning: Health Canada Is Warning Consumers Not to Use Nutural Slim Weight Loss Product
* Reuters is not responsible for the content in this press release.
OTTAWA, ONTARIO, Jun 24 (MARKET WIRE) --
Health Canada is warning consumers not to use the unauthorized product
Nutural Slim, which is promoted as a weight-loss product, as it was found
to contain the undeclared pharmaceutical ingredient sibutramine and also
an undeclared pharmaceutical ingredient similar to sibutramine. Consumers
who have Nutural Slim product are advised to immediately discontinue the
use of this product.
Sibutramine is a prescription drug used to treat obesity. The use of
sibutramine may cause serious side-effects, including cardiovascular
reactions, such as increased blood pressure, chest pain, and stroke.
Other side effects include dry mouth, difficulty sleeping and
constipation. Sibutramine should only be used under the supervision of a
healthcare practitioner.
Sibutramine should not be taken by people who have had a heart attack,
coronary artery disease, heart-related chest pain, irregular heart beats,
congestive heart failure, a stroke or symptoms of a stroke, in
individuals with controlled or poorly controlled high blood pressure, or
in patients who are depressed or have a psychiatric illness. Sibutramine
is not recommended for women who are pregnant, breastfeeding or planning
to become pregnant.
Nutural Slim is not authorized for sale in Canada and has been recalled
by the distributor from the Canadian marketplace. The product label
indicates the manufacturer of the product to be Yingtai TCM Pharma Co.
Health Canada warns Canadians consumers not to purchase these products
from the Internet or from any other source.
Health Canada advises retailers to remove Nutural Slim products from
their shelves, and consumers to return the product to the point of
purchase. Health Canada is taking steps to confirm that the product has
been removed from the Canadian market.
Health Canada advises consumers not to use Nutural Slim, or any other
unauthorized health product, as they may pose a risk to health.
Authorized health products will bear either an eight-digit Drug
Identification Number (DIN), a Natural Product Number (NPN), or a
Homeopathic Medicine Number (DIN-HM) on the label. This authorization
indicates that the product has been assessed by Health Canada for safety,
effectiveness and quality. Health Canada recommends that consumers talk
to a health care practitioner about authorized products for weight loss.
Consumers who are concerned about symptoms possibly associated with the
use of these products should consult with their health care practitioner.
Consumers requiring more information about this advisory can contact
Health Canada's public enquiries line at (613) 957-2991, or toll free at
1-866-225-0709.
Images of Nutural Slim product are available at the following address:
http://media3.marketwire.com/docs/Nutural_slim_e.pdf
To date, no adverse reactions from the use of this product have been
reported in Canada.
You can report any adverse reactions associated with the use of health
products to the Canada Vigilance Program by one of the following three
ways:
- Report online
(http://www.hc-sc.gc.ca/dhp-mps/medeff/report-declaration/index-eng.php)
at the MedEffect(TM) Canada Web site (www.healthcanada.gc.ca/medeffect)
- Call toll-free at 1-866-234-2345
- Complete a Canada Vigilance Reporting Form
(http://www.hc-sc.gc.ca/dhp-mps/medeff/report-declaration/ar-ei_form-eng.php)
and either:
-- Fax toll-free to 1-866-678-6789
-- Mail to: Canada Vigilance Program
Health Canada
AL 0701C
Ottawa, ON K1A 0K9
To have postage pre-paid, download the postage paid label
(http://www.hc-sc.gc.ca/dhp-mps/medeff/report-declaration/post_paid-affranchi-en
.php)
from the MedEffect(TM) Canada Web site
(http://www.hc-sc.gc.ca/dhp-mps/medeff/index-eng.php) The Canada
Vigilance Reporting Form
(http://www.hc-sc.gc.ca/dhp-mps/medeff/report-declaration/ar-ei_form-eng.php)
and the adverse reaction reporting guidelines may also be obtained via
this website.
Egalement disponible en francais
Contacts:
Media Inquiries:
Health Canada
613-957-2983
Public Inquiries:
613-957-2991
1-866-225-0709
Copyright 2009, Market Wire, All rights reserved.
-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.



Follow Reuters